Introduction
En-bloc EMR or ESD is recommended for large non-pedunculated colorectal polyps (LNPCP) harbouring low-risk, submucosal invasive cancer (LR-SMIC). Guidelines recommend ESD for JNET2B rectal lesions, or those with non-granular LST (LST-NG), mixed granular, nodular LST >20 mm (LST-G-MN), bulky morphology, or depressed and irregular pit with demarcation.1 However, ESD capacity in the UK is limited, and referral is constrained by long waiting times, risking disease progression. Tertiary-centre studies report a number-needed-to-treat (NNT) for ESD to achieve 1 curative LR-SMIC of 12–100, but these estimates represent pre-selected cohorts and underestimates the NNT at the point of secondary-care triage. We aimed to quantify the number-needed-to-refer for ESD (NNR-ESD) in an unselected large secondary-care LNPCP cohort.
Aims & Methods
A prospectively maintained database of LNPCP resected at a high-volume single institution was analysed. Expert optical diagnosis and resection were performed during the same procedure. Lesions suspected for SMIC-deep (SMIC-D) were directed to surgery. A universal EMR strategy was performed for all LNPCPs with attempted en-bloc for lesions <25 mm, or of the dominant nodule in LST-G-MN. The primary outcome was the number of LNPCP harbouring LR-SMIC that would have benefited from ESD referral (NNR-ESD) stratified by location and morphology, and the long-term outcomes of these lesions.
Results
Between 01/01/2010 to 01/10/25, 1,376 LNPCP were assessed. Lesions harbouring SMIC were identified in 16.2% (223/1,376). Of these, the benefit from ESD referral was excluded in 92.4% (206/223) due to: a) successful en-bloc EMR (n=20), b) histological high-risk features of cancer (n=152), c) expert optical diagnosis of SMIC-D (n=26), or d) radiological evidence of T3 or N1 (n=8). The NNR-ESD to identify 1 case of LR-SMIC was 81 (all patients), 48 (left-sided), 25 (left-sided-NG), 333 (right-sided), 104 (right-sided-NG) (Table 1). Of the remaining 1.2% (17/1376) identified as LR-SMIC that could have benefited from ESD referral, 6 accepted secondary surgery (all pT0N0), and 5 remained alive and disease-free after median 80 months (IQR 34-117), and 1 died from distant colorectal cancer metastases at 22 months. Of the 11 who declined secondary surgery, 7 remained disease free (median 51 months, IQR 24-84) and 4 died of non-CRC cause (median 94 months, IQR 36-137).
Table 1. Number-needed to refer for ESD stratified by polyp morphology and LR-SMIC status
|
|
|
|
|---|
LNPCP, Large non-pedunculated colorectal polyp; NG, non-granular; LR-SMIC, low risk submucosal-invasive cancer; NNR-ESD, number-needed-to-refer for ESD $LR-SMIC defined as submucosal invasion (SMI) ≤1 mm, well/moderate differentiation, no lymphovascular invasion) *Lesions distal to the splenic flexure (inclusive) were considered left-sided. All other lesions were considered right-sided
|
|
|
|
| Polyp Morphology | Total Number (n) | $LR-SMIC, n (%) | NNR-ESD |
All LNPCP - All Left-sided* - Non-NG - NG - All Right-sided - Non-NG - NG | 1376 712 638 74 663 559 104
| 17 (1.2%) 15 (2.1) 12 (1.9) 3 (4.1) 2 (0.3) 1 (0.2) 1 (1.0)
| 81 48 53 25 332 559 104
|
Conclusion
In this large unselected secondary-care cohort, only 1.2% of LNPCP harboured LR-SMIC that would have benefited from ESD referral, with an NNR-ESD clinically meaningful only for left-sided NG lesions. Critically, the NNR-ESD represents a referral burden, not a definitive treatment benefit, for which, even in expert hands, ESD achieves R0 resection in only 75–85% of cases. In our cohort, two-thirds of LR-SMIC managed with EMR remained disease-free; hence, the NNT for ESD to achieve an outcome superior to EMR would substantially exceed the NNR-ESD. These data support a highly selective, morphology- and location-driven triage strategy for ESD referral and challenge the assumption that broader ESD access would meaningfully improve outcomes at a population level.
References
1) Pimentel-Nunes P, Libânio D, Bastiaansen BA, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline–Update 2022. Endoscopy. 2022 Jun;54(06):591-622.